Stifel Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.7M | Buy |
183,027
+17,047
| +10% | +$1.41M | 0.01% | 763 |
|
|
2025
Q4 | $14.1M | Sell |
165,980
-2,011
| -1% | -$165K | 0.01% | 790 |
|
|
2025
Q3 | $13.1M | Sell |
167,991
-21,289
| -11% | -$1.66M | 0.01% | 828 |
|
|
2025
Q2 | $14.8M | Sell |
189,280
-42,717
| -18% | -$3.19M | 0.01% | 719 |
|
|
2025
Q1 | $16.8M | Buy |
231,997
+8,140
| +4% | +$583K | 0.02% | 631 |
|
|
2024
Q4 | $16.6M | Sell |
223,857
-8,881
| -4% | -$622K | 0.02% | 638 |
|
|
2024
Q3 | $15.4M | Buy |
232,738
+24,731
| +12% | +$1.8M | 0.02% | 694 |
|
|
2024
Q2 | $19.2M | Sell |
208,007
-3,932
| -2% | -$348K | 0.02% | 562 |
|
|
2024
Q1 | $20.3M | Sell |
211,939
-22,549
| -10% | -$1.89M | 0.02% | 546 |
|
|
2023
Q4 | $17.9M | Buy |
234,488
+20,447
| +10% | +$1.42M | 0.02% | 557 |
|
|
2023
Q3 | $14.8M | Sell |
214,041
-16,688
| -7% | -$1.34M | 0.02% | 572 |
|
|
2023
Q2 | $21.8M | Buy |
230,729
+4,694
| +2% | +$408K | 0.03% | 446 |
|
|
2023
Q1 | $18.7M | Sell |
226,035
-132,237
| -37% | -$10.4M | 0.03% | 483 |
|
|
2022
Q4 | $26.7M | Sell |
358,272
-88,706
| -20% | -$6.84M | 0.04% | 376 |
|
|
2022
Q3 | $36.9M | Buy |
446,978
+454
| +0.1% | +$43.7K | 0.06% | 282 |
|
|
2022
Q2 | $42.5M | Buy |
446,524
+1,748
| +0.4% | +$181K | 0.07% | 265 |
|
|
2022
Q1 | $52.4M | Buy |
444,776
+71,181
| +19% | +$7.99M | 0.07% | 251 |
|
|
2021
Q4 | $48.4M | Sell |
373,595
-8,583
| -2% | -$1M | 0.06% | 260 |
|
|
2021
Q3 | $43.3M | Sell |
382,178
-6,697
| -2% | -$764K | 0.06% | 268 |
|
|
2021
Q2 | $40.3M | Sell |
388,875
-26,928
| -6% | -$2.54M | 0.06% | 276 |
|
|
2021
Q1 | $34.8M | Sell |
415,803
-13,922
| -3% | -$1.18M | 0.06% | 284 |
|
|
2020
Q4 | $39.2M | Buy |
429,725
+44,459
| +12% | +$3.69M | 0.07% | 254 |
|
|
2020
Q3 | $30.8M | Buy |
385,266
+52,788
| +16% | +$4.12M | 0.06% | 269 |
|
|
2020
Q2 | $23M | Sell |
332,478
-3,669
| -1% | -$261K | 0.05% | 298 |
|
|
2020
Q1 | $21.2M | Sell |
336,147
-194,730
| -37% | -$14M | 0.06% | 280 |
|
|
2019
Q4 | $41.3M | Buy |
530,877
+12,255
| +2% | +$957K | 0.09% | 227 |
|
|
2019
Q3 | $38M | Sell |
518,622
-510
| -0.1% | -$35.8K | 0.1% | 215 |
|
|
2019
Q2 | $32M | Buy |
519,132
+16,701
| +3% | +$1.01M | 0.08% | 238 |
|
|
2019
Q1 | $32M | Buy |
502,431
+9,321
| +2% | +$532K | 0.09% | 228 |
|
|
2018
Q4 | $25.2M | Sell |
493,110
-6,735
| -1% | -$341K | 0.08% | 239 |
|
|
2018
Q3 | $29M | Buy |
499,845
+50,445
| +11% | +$2.47M | 0.08% | 239 |
|
|
2018
Q2 | $21.8M | Buy |
449,400
+5,598
| +1% | +$261K | 0.07% | 287 |
|
|
2018
Q1 | $20.6M | Buy |
443,802
+3,525
| +0.8% | +$153K | 0.07% | 297 |
|
|
2017
Q4 | $16.6M | Buy |
440,277
+286,200
| +186% | +$10.5M | 0.05% | 356 |
|
|
2017
Q3 | $5.62M | Buy |
154,077
+13,914
| +10% | +$531K | 0.02% | 688 |
|
|
2017
Q2 | $5.53M | Sell |
140,163
-13,278
| -9% | -$485K | 0.02% | 680 |
|
|
2017
Q1 | $4.82M | Buy |
153,441
+21,351
| +16% | +$668K | 0.02% | 710 |
|
|
2016
Q4 | $4.12M | Buy |
132,090
+51,744
| +64% | +$1.68M | 0.02% | 729 |
|
|
2016
Q3 | $3.22M | Sell |
80,346
-63,531
| -44% | -$2.39M | 0.01% | 802 |
|
|
2016
Q2 | $4.78M | Sell |
143,877
-294
| -0.2% | -$10.1K | 0.02% | 629 |
|
|
2016
Q1 | $4.24M | Sell |
144,171
-1,548
| -1% | -$42.7K | 0.02% | 611 |
|
|
2015
Q4 | $3.84M | Buy |
145,719
+17,157
| +13% | +$446K | 0.02% | 683 |
|
|
2015
Q3 | $3.04M | Buy |
128,562
+4,836
| +4% | +$117K | 0.02% | 739 |
|
|
2015
Q2 | $2.94M | Buy |
123,726
+1,302
| +1% | +$29.4K | 0.02% | 794 |
|
|
2015
Q1 | $2.91M | Sell |
122,424
-41,238
| -25% | -$925K | 0.02% | 788 |
|
|
2014
Q4 | $3.47M | Sell |
163,662
-64,338
| -28% | -$1.29M | 0.02% | 697 |
|
|
2014
Q3 | $3.88M | Buy |
228,000
+15,864
| +7% | +$250K | 0.03% | 554 |
|
|
2014
Q2 | $3.04M | Sell |
212,136
-72,738
| -26% | -$986K | 0.03% | 626 |
|
|
2014
Q1 | $3.52M | Buy |
+284,874
| New | +$3.29M | 0.03% | 562 |
|
Other funds holding EW
VCM
VPM
Stifel Financial's EW Position: Q1 2026 in Review
Stifel Financial increased its Edwards Lifesciences (EW) stake by 10% in Q1 2026, buying an estimated $1.41M and bringing the position to 183,027 shares worth $14.7M. The position accounts for 0.01% of the portfolio, ranked #763.
Stifel Financial first reported a position in EW in Q1 2014 and has held it in 49 quarters since. The position peaked at $52.4M in Q1 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Stifel Financial held 183,027 shares of Edwards Lifesciences worth $14.7M as of Q1 2026.
- Stifel Financial bought 17,047 Edwards Lifesciences shares in Q1 2026, an estimated $1.41M.
- Edwards Lifesciences made up 0.01% of Stifel Financial's portfolio in Q1 2026, its #763 holding.
- Stifel Financial first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Edwards Lifesciences position peaked at $52.4M in Q1 2022.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.